Hericium erinaceus: an edible fungus under study

Hericium erinaceus is a wood-inhabiting fungus of the family Hericiaceae. It is known in English as lion's mane, in German as Igelstachelbart and in Japanese as yamabushitake. Its fruiting body forms a rounded white mass from which long, soft spines hang downwards, which is the origin of all three common names. The species has been eaten in East Asia for centuries and has been cultivated commercially since the second half of the twentieth century.

Biology and natural occurrence

Hericium erinaceus grows on dead or dying hardwood, preferentially beech, oak and maple. It enters the wood through wounds and breaks down lignin and cellulose, which makes it a white rot fungus. Fruiting bodies appear mainly in late summer and autumn and can reach a diameter of 25 centimetres. In Central Europe the species is uncommon and in several regions it is legally protected, so wild collection is restricted; material on the market comes from cultivation.

Two further species of the same genus, Hericium coralloides and Hericium americanum, look similar and are sometimes confused with it. Commercial cultivation uses defined strains grown on sterilised hardwood sawdust substrate, usually supplemented with bran, in bags under controlled humidity and temperature.

Composition

The fresh fruiting body consists of roughly 90 per cent water. The dry matter contains protein, dietary fibre including beta-glucans, small amounts of fat and a range of minerals. Beyond these basic nutrients, the following compound classes have attracted the attention of chemists:

  • Hericenones: aromatic compounds isolated from the fruiting body. They are named after the genus and were first described in Japanese work in the 1990s.
  • Erinacines: diterpenoids found mainly in the mycelium rather than the fruiting body. Erinacine A is the best characterised member.
  • Beta-glucans: branched polysaccharides typical of fungal cell walls, which are studied in immunology across many mushroom species.
  • Phenolic compounds and ergothioneine: substances with measurable radical-scavenging activity in chemical assays. Such assays describe behaviour in a test tube and say nothing about what happens in the body.

The content of these compounds differs substantially between fruiting body and mycelium, between strains and between extraction methods. Hot water extraction concentrates polysaccharides, ethanol extraction concentrates the hericenones and erinacines. A product labelled simply as extract may therefore contain very different material from one labelled as powdered fruiting body.

Culinary use

The fruiting body has a firm, fibrous texture that is often compared to crab or scallop meat, and the flavour is mild. In the kitchen it is used in the following ways:

  • Pan-fried: sliced and cooked until the surface browns; the dense texture holds up well to heat.
  • In soups and sauces: it takes on the flavour of the liquid it is cooked in.
  • As a meat alternative: the fibrous structure makes it a common ingredient in vegetarian cooking.
  • Dried: dried pieces are ground as a seasoning or infused as a tea.

Like all wild and cultivated mushrooms, Hericium erinaceus should be cooked before eating. Raw fungal material is difficult to digest because of its chitinous cell walls.

What research has examined

Hericium erinaceus has been investigated in cell culture, in rodents and in a small number of human trials. The following summarises what the literature reports, with the model indicated in each case:

  • Nerve growth factor in cell culture: hericenones and erinacines were identified in screening experiments in which cultured cells were observed to release more nerve growth factor. This is a cell-culture observation; whether the compounds reach the human brain in relevant amounts after oral intake is unresolved, and erinacines in particular are found in mycelium, not in the fruiting bodies normally eaten.
  • Rodent studies: experiments in mice and rats have used extracts of fruiting body or mycelium and measured behavioural test performance, nerve regeneration after injury and markers in brain tissue. Results are reported in the respective animal model and cannot be transferred to humans.
  • Human trials: a Japanese trial published in 2009 gave an extract to 30 older adults with mild cognitive complaints over 16 weeks and reported differences in a cognitive test score between groups, which diminished after intake stopped. A further small Japanese study in 30 women examined questionnaire scores over four weeks. Both trials had few participants, ran for a short time and have not been replicated at scale.
  • Immunological work: fungal beta-glucans are studied across many species for their interaction with receptors on immune cells. This research is largely preclinical.

Taken together, the human evidence consists of a handful of small trials with different preparations and different endpoints. No conclusion about effects in people can be drawn from this body of work at present.

Forms and amounts used in studies

Material is sold as dried fruiting body powder, as hot water or dual extract, and in capsules. Extract products often carry a ratio such as 8:1, which states how much raw material went into one part of extract but says nothing about which compounds were concentrated. Human trials have worked with study doses in the range of 1 to 3 grams of powder or extract per day; these figures describe the study protocols.

Tolerability and cautions

Hericium erinaceus is regarded as an edible mushroom with a long history of consumption. Reported adverse reactions are mostly mild gastrointestinal discomfort. Allergic reactions, including skin reactions and respiratory symptoms, have been described in isolated case reports, and people with known mould or fungal allergies should take this into account. Data on intake during pregnancy and breastfeeding are lacking, and medical advice before use is appropriate in those situations and in the presence of existing medical conditions or medication.

Regulatory status in the European Union

The fruiting body of Hericium erinaceus has a history of food use in the EU. Mycelium-based preparations and concentrated extracts are assessed case by case and may fall under the Novel Food Regulation depending on the production process and the intended use. No health claim for Hericium erinaceus is authorised in the EU, so products may not be sold with statements about cognition, mood or immune function.